montelukast + placebo

This is a combination of montelukast, a leukotriene receptor antagonist, and placebo. Montelukast is an oral small molecule medication used for the prevention and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis (both seasonal and perennial). It works by selectively blocking cysteinyl leukotriene type-1 receptors in the airways, thereby reducing inflammation, bronchoconstriction, mucus secretion, and eosinophil recruitment. Placebo is an inert substance with no pharmacological activity; it is commonly used as a control in clinical trials to assess the efficacy of active drugs like montelukast[1][2][5]. This combination typically refers to arms in clinical studies where one group receives active drug (montelukast) while another receives placebo.

Other names

placebo + montelukast